The Effect of the California Tobacco Control Program on Smoking Prevalence, Cigarette Consumption, and Healthcare Costs: 1989–2008

Lightwood, James; Glantz, Stanton A.
February 2013
PLoS ONE;Feb2013, Vol. 8 Issue 2, p1
Academic Journal
Background: Previous research has shown that tobacco control funding in California has reduced per capita cigarette consumption and per capita healthcare expenditures. This paper refines our earlier model by estimating the effect of California tobacco control funding on current smoking prevalence and cigarette consumption per smoker and the effect of prevalence and consumption on per capita healthcare expenditures. The results are used to calculate new estimates of the effect of the California Tobacco Program. Methodology/Principal Findings: Using state-specific aggregate data, current smoking prevalence and cigarette consumption per smoker are modeled as functions of cumulative California and control states' per capita tobacco control funding, cigarette price, and per capita income. Per capita healthcare expenditures are modeled as a function of prevalence of current smoking, cigarette consumption per smoker, and per capita income. One additional dollar of cumulative per capita tobacco control funding is associated with reduction in current smoking prevalence of 0.0497 (SE.00347) percentage points and current smoker cigarette consumption of 1.39 (SE.132) packs per smoker per year. Reductions of one percentage point in current smoking prevalence and one pack smoked per smoker are associated with $35.4 (SE $9.85) and $3.14 (SE.786) reductions in per capita healthcare expenditure, respectively (2010 dollars), using the National Income and Product Accounts (NIPA) measure of healthcare spending. Conclusions/Significance: Between FY 1989 and 2008 the California Tobacco Program cost $2.4 billion and led to cumulative NIPA healthcare expenditure savings of $134 (SE $30.5) billion.


Related Articles

  • The impact of changes in tobacco control funding on healthcare expenditures in California, 2012-2016. Max, Wendy; Hai-Yen Sung; Lightwood, James // Tobacco Control;May2013 Supplement, Vol. 22, pe10 

    Objective This study presents estimates of the impact of changes in California tobacco control funding on healthcare expenditures for 2012-2016 under four funding scenarios. Methods Smoking prevalence is projected using a cointegrated time series regression model. Smoking-attributable healthcare...

  • "HEALTHY PEOPLE" AND TOBACCO POLICY IN THE U.S. Small, Carolyn // Focus Journal;Spring2012, p12 

    The article discusses the history of and developments in tobacco policy in the U.S. The first landmark report on the dangers of smoking was published by the Surgeon General in 1964, while the first set of national target goals for health in Healthy People 1990 was published in 1979. The goal of...

  • Stop-smoking services' costs soar. Praities, Nigel // Pulse;6/9/2010, Vol. 70 Issue 20, p6 

    The article reports on the rising cost of primary care organizations' (PCO) National Health Service (NHS) stop-smoking services due to over-reliance on specialist services in Great Britain.

  • The Quit Benefits Model: a Markov model for assessing the health benefits and health care cost savings of quitting smoking. Hurley, Susan F.; Matthews, Jane P. // Cost Effectiveness & Resource Allocation;2007, Vol. 5, p2 

    Background: In response to the lack of comprehensive information about the health and economic benefits of quitting smoking for Australians, we developed the Quit Benefits Model (QBM). Methods: The QBM is a Markov model, programmed in TreeAge, that assesses the consequences of quitting in terms...

  • Unrelated Medical Costs in Life-Years Gained: Should They be Included in Economic Evaluations of Healthcare Interventions? Rappange, David R; van Baal, Pieter H. M.; van Exel, N. Job A.; Feenstra, Talitha L.; Rutten, Frans F. H.; Brouwer, Werner B. F. // PharmacoEconomics;2008, Vol. 26 Issue 10, p815 

    Which costs and benefits to consider in economic evaluations of healthcare interventions remains an area of much controversy. Unrelated medical costs in life-years gained is an important cost category that is normally ignored in economic evaluations, irrespective of the perspective chosen for...

  • Smoking cessation therapy: reimbursement worth it?  // PharmacoEconomics & Outcomes News;7/1/2006, Issue 506, p6 

    This article discusses research being done on the reimbursement of smoking cessation therapy. It references a study by J. Kaper et al published in a 2006 issue of "PharmacoEconomics." The cost effectiveness of reimbursement for smoking cessation treatment in smokers was calculated. Information...

  • Live long, prosper and send the bill to health care.  // Active Living;Mar2008, Vol. 17 Issue 2, p4 

    The article reports on the study which reveals reasons for stopping smoking and losing weight. The study shows that one of the main reasons for stopping smoking and losing weight has been the cost savings for the Medicare system. It notes that the health care costs of long-lived, thin, adults...

  • Health evaluation and referral assistant: a randomized controlled trial to improve smoking cessation among emergency department patients. Boudreaux, Edwin D.; Abar, Beau; Haskins, Brianna; Bauman, Brigitte; Grissom, Grant // Addiction Science & Clinical Practice;11/5/2015, Vol. 10, p1 

    Background: Computer technologies hold promise for implementing tobacco screening, brief intervention, and referral to treatment (SBIRT). This study aims to evaluate a computerized tobacco SBIRT system called the Health Evaluation and Referral Assistant (HERA). Methods: Smokers (n = 421)...

  • Smoking cessation counselling cost effective in hospital.  // PharmacoEconomics & Outcomes News;Jul2014, Vol. 707 Issue 1, p7 

    The article discusses research being done on smoking cessation counseling in hospital which references the study "Study Shows Cost-Effectiveness of Smoking Cessation Counseling During Hospitalization" featured in the Web site of the University of Ottawa Heart Institute.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics